Shuffler News
Parkinsons and Dopamine Agonists, a story !
The words of someone who has been to hell and back and still climbing out of it.
“Agonists are like your best friend acting nice, but in the bigger picture they have an alterior motive far more sinister than any benefit that the friendship could ever provide.
For most it works, but my experience was stomach churningly horrendous, with life long repucussions of the highest order, loss of business, reputation, family houses, economic and social supports.
Structured social and medical supports, as well as paitent suitability given patient personailty and lifestyle, are required that extend way beyond what the medical profession currently offers .
These supports need to look for and continually monitor for the hidden signals, behaviour changes, reclusiveness, adverse risk taking, clouded judgement, as the participant can very easily deliberately hide the obvious signs of compulsive behaviour, which may seem trivial to those looking in, but will rock the foundations for the person who sought the benefit, ripping their insides with decay and leaving a shell of a human with nothing left inside.”
There is a moral duty of care that isn’t being acknowledged, and those affected are too proud to publicly admit that they fell prey to the fiery forks of the devil disguised.
This could never happen to me, I won’t be judged by my friends so I’ll keep it to myself”
Stories from Agonist Survivors
Parkinsons: Dopamine Agonists. Dangers !
Learning to Pay Attention to the ‘Histamine Flicker’
I was surprised to discover a link between my chronic runny nose and Parkinson’s disease (PD) while I was doing research on the effect of over-the-counter antihistamines on PD medications. I have always thought that
Epilepsy Therapy Zonisamide Found to Reduce Parkinson’s ‘Off’ Time
Treatment with zonisamide — an approved epilepsy medication — can reduce “off” time without worsening treatment side effects in people with Parkinson’s disease, a new analysis of Japanese clinical trial data shows. Notably, the use
HealthWell Opens Fund to Help Parkinson’s Patients With Psychosis
The HealthWell Foundation has opened a fund to support people with Parkinson’s or other neurocognitive diseases in the U.S. who also are being treated for psychosis. To be eligible, patients must have a psychosis diagnosis,
‘Movin’ It’ With Hip Hop Dance Classes for People With Parkinson’s
“I like to move it, move it. I like to move it, move it. I like to move it!” These dance tune lyrics, interpreted in the animated children’s movie “Madagascar,” reflect an unfortunate reality for
Supernus to Acquire Adamas and Its Therapies, Gocovri and Osmolex ER
Two established Parkinson’s disease (PD) treatments — Gocovri (amantadine) and Osmolex ER (amantadine hydrochloride) — will move to Supernus’ Pharmaceuticals when it completes an agreement now in place for it to acquire Adamas Pharmaceutical. The $450 million
Extended Dosing Improves Safety of IkT-148009, Animal Studies Show
The safety profile of IkT-148009, an investigational oral medication for Parkinson’s disease, improved the longer the drug was dosed, demonstrating target selectivity, according to interim three-month animal data. The ongoing toxicology studies, conducted by the
Hobbies and Leisure Activities Help My Sister Manage Parkinson’s Disease
My sister Bev, who has stage 3 Parkinson’s disease (PD), loves to bake. Although she has moderate cognitive issues, baking and gardening are things she can still do well. Despite her Parkinson’s, these hobbies help
MJFF Details Need for Diversity in Parkinson’s Research, Care
Current understanding of Parkinson’s disease does not reflect patients from diverse socioeconomic or ethnic backgrounds, and they remain poorly represented in research, according to a position paper from The Michael J. Fox Foundation for Parkinson’s
Partnership to Expand Prescription Music Catalog for Walking Therapy
MedRhythms, which is pioneering rhythmic auditory stimulation to improve walking ability in people with neurological disorders, has now launched a partnership with Universal Music Group (UMG) — owner of a vast catalog of recordings and songs
Parkinson’s Voice Project’s Annual Virtual Choir Concert Set for Nov. 6
The Parkinson Voice Project (PVP) is hosting its second annual Parkinson’s Virtual Choir Concert on Nov. 6, with more than 300 Parkinson’s disease patients from around the world and their family members and friends taking part.
Posts from the author
Shufflernews
Parkinsons
Subscribe
Phone
0490 33 22 68
shuffles@shufflenews.com